BMT Tandem "Scientific" Meeting
Seaport Ballroom DE (Manchester Grand Hyatt)
Chairs:
Yi-Bin Chen, MD
and
Mitchell E. Horwitz, MD
Disclosures:
Y. B. Chen,
Seattle Genetics:
Research Funding
Novartis:
Research Funding
Millennium:
Consultancy
Ariad:
Consultancy
Bayer:
Consultancy
and
Research Funding
M. E. Horwitz,
Genzyme/Sanofi, Investigator:
Research Funding
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Rehan Mujeeb Faridi, PhD, University of Calgary;
Taylor J Kemp, University of Calgary;
Poonam Dharmani, PhD, University of Calgary;
Victor Lewis, MD, Alberta Children's General Hospital;
Noureddine Berka, PhD, Calgary Laboratory Services;
Jan Storek, MD, PhD, Tom Baker Cancer Centre/Foothills Hospital;
Faisal Khan, PhD, University of Calgary
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Alicia McFarren, MD, Children's Hospital of Los Angeles;
P. Brian Smith, MD, MPH, Duke University Medical Center;
Kristin Page, MD, Duke University Medical Center;
Heather B Allewelt, MD, Duke University Medical Center;
Suhag Parikh, MD, Duke University Medical Center;
Timothy A Driscoll, MD, Duke University Medical Center;
Paul L. Martin, MD, PhD, Duke University Medical Center;
Joanne Kurtzberg, MD, Duke University Medical Center;
Vinod K. Prasad, MD, Duke University Medical Center
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Daniel Fürst, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Christine Zollikofer, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Carlheinz Müller, MD, PhD, DRST – German Registry for Stem Cell Transplantation;
Dietger Niederwieser, MD, University of Leipzig;
Donald W. Bunjes, MD, University of Ulm;
Eva Wagner, MD, Johannes Gutenberg-University Mainz;
Martin Gramatzki, MD, University of Kiel;
Gerald Wulf, Georg-August-University Göttingen;
Renate Arnold, MD, Charité - Universitätsmedizin Berlin;
Hermann Einsele, MD, University Hospital of Wuerzburg;
Bertram Glass, MD, Asklepios Klinik St. Georg;
Gernot Stuhler, Deutsche Klinik für Diagnostik;
Micheal Pfreundschuh, University Clinic of Saarland;
Hubert Schrezenmeier, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Joannis Mytilineos, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT)
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Said Yousuf Mohamed, MD, King Faisal Specialist Hospital;
Hazzaa Alzahrani, KFSHRC;
Khaled T Ibrahim, KFSHRC, Oncology Center, KFSHRC, SA;
Ghada Elgohary, , KFSHRC, Oncology Center, KFSHRC, SA;
Ahmed Y Gamal, KFSHRC, Oncology Center, KFSHRC, SA;
Amr Hanbali, KFSHRC, Oncology Center, KFSHRC, SA;
Marwan Shaheen, KFSHRC, Oncology Center, KFSHRC, SA;
Walid K. Rasheed, KFSHRC, Oncology Center, KFSHRC, SA;
Wahiba Chebbo, KFSHRC, Oncology Center, KFSHRC, SA;
Osama Ali, KFSHRC, Oncology Center, KFSHRC, SA;
Rehab Albloushi, KFSHRC, Oncology Center, KFSHRC, SA;
Ahmad Alhuraiji, KFSHRC, Oncology Center, KFSHRC, SA;
Naeem Chaudri, KFSHRC, Oncology Center, KFSHRC, SA;
Syed O Ahmed, KFSHRC, Oncology Center, KFSHRC, SA;
Tussneem El-Hassan, KFSHRC, Oncology Center, KFSHRC, SA;
Mahmoud Deeb Aljurf, King Faisal Specialist Hospital;
Fahad Al-Mohareb, KFSHRC, Oncology Center, KFSHRC, SA
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Michael A. Pulsipher, MD, University of Utah School of Medicine;
Brent R. Logan, PhD, Medical College of Wisconsin;
Deidre M. Kiefer, M.P.H., Center for International Blood and Marrow Transplant Research, National Marrow Donor Program;
Pintip Chitphakdithai, PhD, National Marrow Donor Program;
Tanya L. Pedersen, MPH, Allina Health;
David F. Stroncek, MD, Clinical Center, NIH;
Eric P. Williams, PhD, National Marrow Donor Program;
Paul V. O'Donnell, MD, PhD, FACP, Fred Hutchinson Cancer Research Center;
Navneet S. Majhail, MD, MS, Cleveland Clinic;
Dennis L. Confer, MD, National Marrow Donor Program;
Bronwen E. Shaw, MD, PhD, CIBMTR and Medical College of Wisconsin
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Michael A. Pulsipher, MD, University of Utah School of Medicine;
Brent R. Logan, PhD, Medical College of Wisconsin;
Deidre M. Kiefer, M.P.H., Center for International Blood and Marrow Transplant Research, National Marrow Donor Program;
Pintip Chitphakdithai, PhD, National Marrow Donor Program;
Galen E. Switzer, PhD, University of Pittsburgh;
Marcie L. Riches, MD, MS, H. Lee Moffitt Cancer Center and Research Institute;
J. Douglas Rizzo, MD, MS, CIBMTR and Medical College of Wisconsin;
Paolo Anderlini, MD, UT MD Anderson Cancer Center;
Susan F. Leitman, MD, National Heart Lung and Blood Institute - NIH;
James W. Varni, PhD, Texas A&M University;
Hati Kobusingye, MS, National Marrow Donor Program;
RaeAnne M. Besser, BS, National Marrow Donor Program;
John P. Miller, MD, PhD, National Marrow Donor Program;
Rebecca J. Drexler, BS, AAS, National Marrow Donor Program;
Roberta J. King, MPH, CIBMTR/National Marrow Donor Program;
Mary M. Horowitz, MD, MS, CIBMTR and Medical College of Wisconsin;
Dennis L. Confer, MD, National Marrow Donor Program
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Michael Punzel, Medical Faculty Heinrich-Heine-University Duesseldorf;
Jutta Rox, Medical Faculty Heinrich-Heine-University Duesseldorf;
Karin Buhrmann, Cellex Cologne;
Helmuth Schmidt, Cellex Cologne;
Anna Kozlova, Cellex Cologne;
Tilo Robitzsch, Medical Faculty Heinrich-Heine-University Duesseldorf;
Annegret Quade, MVZ Labor Quade;
Carsten Bartling, MVZ Labor Quade;
Gerhard Ehninger, Cellex Cologne;
Johannes C Fischer, Medical Faculty Heinrich-Heine-University Duesseldorf
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Bipin N. Savani, MD, Vanderbilt University Medical Center;
Myriam Labopin, MD, EBMT Paris study office / CEREST-TC;
Emmanuelle Polge, Université Pierre et Marie Curie;
Didier Blaise, MD, Institut Paoli Calmettes;
Dietger Niederwieser, MD, University of Leipzig;
Fabio Ciceri, MD, San Raffaele Scientific Institute;
Arnold Ganser, MD, Medizinische Hochschule Hannover;
Renate Arnold, MD, Charité - Universitätsmedizin Berlin;
Boris Afanasyev, Saint Petersburg State Medical Pavlov University – Ratsa Gorbacheva Memorial Children`s Institute, Hematology and Transplantology;
Noel Milpied, CHU Bordeaux;
Michael Hallek, University of CologneI - Dept. of Medicine;
Jan Cornelissen, MD, PhD, Dr. Daniel Den Hoed Cancer Center;
Rainer Schwerdtfeger, MD, PhD, DKD - Wiesbaden;
Sebastian Giebel, MD, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch;
Mohamad Mohty, MD, PhD, Department of Haematology, Saint Antoine Hospital;
Arnon Nagler, MD, The Chaim Sheba Medical Center, Tel-Hashomer, Division of Hematology and Bone Marrow Transplantation
![[Visit Client Website]](images/banner.gif)